Purpose: This study aimed to evaluate the value of [F]FDG PET/CT in patients with kidney disease by using multiple metabolic parameters.
Materials And Methods: A retrospective review of 182 kidney disease patients and 32 controls was conducted. Patients were categorized into acute kidney disease (AKD), AKI on CKD (A/C), and chronic kidney disease (CKD) groups, further divided by CKD stage and disease etiology. Regions of interest (ROIs) were drawn in renal cortex, liver, aorta, and lesions. SUVmax and SUVmean were measured, and ratios of renal cortex SUVmax to liver and blood pool SUVmean were calculated.
Results: Abnormal FDG uptake was observed in 84.6 % of patients, with significantly higher SUVmax in malignant versus benign lesions. Common malignancies included multiple myeloma, lymphoma, and lung cancer. PET/CT had 89.5 % sensitivity and 100 % specificity for tumor detection. SUVs differed significantly among AKD, A/C, CKD, and normal groups. Significant differences in SUVmax and SUVmean were also found between CKD stages and primary versus secondary kidney diseases. In CKD, increased SUVmax and SUVmean correlated with lower serum creatinine and blood urea nitrogen, and increased eGFR.
Conclusion: For patients with kidney disease, [F]FDG PET/CT can be used to systematically screen tumors and inflammatory lesions. And the [F]FDG uptake of renal cortex may distinguish different types of kidney diseases and is correlated with renal function.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11870161 | PMC |
http://dx.doi.org/10.1016/j.heliyon.2025.e42522 | DOI Listing |
J Cell Mol Med
March 2025
Department of Cardiology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
Recent research has revealed a close association between obesity and various metabolic disorders, including renal metabolic diseases, but the mechanism is still unknown. This study explored the role of p16INK4a in obesity-related kidney fibrosis and evaluated its potential as a therapeutic target. Using wild-type (WT) mice and p16 KO mice, we fed both groups a high-fat diet (HFD) for 6 months.
View Article and Find Full Text PDFCurr Med Res Opin
March 2025
Division of Rheumatology, Allergy and Immunology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Background: Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disorder that significantly impacts renal function. Despite conventional treatments, morbidity and mortality remain high, necessitating the exploration of safer and more effective therapies, including the potential benefits of Traditional Chinese Medicine (TCM) for improving kidney health and survival rates.
Methods: Patients with newly diagnosed with SLE with catastrophic illness certificate were retrospectively enrolled from CGRD between 2005 and 2020.
Mol Nutr Food Res
March 2025
Graduate Program in Food, Nutrition and Health - Institute of Nutrition, State University of Rio de Janeiro (UERJ), Rio de Janeiro (RJ), Brazil.
Scope: The uremic toxin trimethylamine N-oxide (TMAO) accumulates in patients with chronic kidney disease (CKD) and is associated with its progression, cardiovascular disease, and other complications. The gut microbiota produces TMAO from substrates mainly found in red meat, eggs, and dairy. However, some saltwater fish also contain high levels of TMAO.
View Article and Find Full Text PDFR Soc Open Sci
March 2025
Interface Analysis Centre, HH Wills Physics Laboratory, School of Physics, University of Bristol, Bristol, UK.
Transplantation is the standard treatment for end-stage kidney disease but carries with it a non-trivial risk of post-operative complication. There is a need for a continuous, real-time, not additionally invasive method of monitoring organ perfusion. We present an approach to allograft perfusion monitoring using a human kidney model using normothermic perfusion (EVNP) and custom spectroscopic optical reflectance probes.
View Article and Find Full Text PDFRadiol Bras
February 2025
Department of Radiology, Medical Faculty, Ataturk University, Erzurum, Turkey.
Objective: To assess the frequency of unrecognized myocardial infarction and identify additional ischemic conditions, as well as to evaluate the efficacy of cardiac magnetic resonance imaging (CMRI) in risk groups, comparing the imaging findings with electro-cardiographic (ECG) and laboratory data in patients with stage 5 chronic kidney disease, also known as end-stage renal disease.
Materials And Methods: This was a prospective single-center study involving 20 patients who were referred to our radiology department to undergo CMRI between June 2010 and December 2011. Resting left ventricular functions and (early and late) myocardial contrast enhancement were assessed in all patients.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!